Dr. Stephen C. Hurlbut, MD

Dr. Hurlbut practices at Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources.

Dr. Hurlbut's NPI, 1699750836, was assigned on December 9, 2005. Dr. Hurlbut graduated from UTMB Health in 1990. Dr. Hurlbut's Texas license number on file is J7995.

Dr. Hurlbut's primary practice is Texas Health Fort Worth, at 1301 Pennsylvania Avenue, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 250-2100.

Dr. Hurlbut's primary practice is Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources. Dr. Hurlbut is also affiliated with CHI Health Mercy Council Bluffs. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Hurlbut to 1 more hospital, 4 medical groups, 3 group practices and clinics and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hurlbut practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Hurlbut's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Hurlbut is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Hurlbut's licenses on file in 15 states: Texas, South Dakota, Delaware, Illinois, Alabama, Colorado, Iowa, Kansas, Louisiana, Minnesota, Mississippi, New Jersey, Oklahoma, Tennessee and Wisconsin.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, cerebrovascular disease, encephalopathy, epilepsy, essential tremor, fibromyalgia and chronic pain and head injury among the conditions Dr. Hurlbut treats.

CMS data shows 1,014 Medicare services from Dr. Hurlbut across 7 procedure codes in 2024, for 540 Medicare patients. Medicare paid $94,479 for them. Every service was in an office.

CMS counts 540 Medicare patients who saw Dr. Hurlbut in 2024. The largest group is 65 to 74, with 212 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hurlbut's median patient age at 70, with 64% women.

In 2024, Dr. Hurlbut wrote 6,577 Medicare Part D claims for 696 patients. 91% of them were for generic drugs. CMS names the drug for 6,294 of them, across 107 drugs with 11 or more claims each, at $1,424,743 in total drug cost. In 2023, CMS named 6,421 claims across 102 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Hurlbut for performance year 2024, reported individually. Dr. Hurlbut accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hurlbut as offering telehealth.

Dmand AI links 6 papers to Dr. Hurlbut. The most frequent topics are Alcoholism, Ambulatory Care and Carcinoid Tumor. Dr. Hurlbut's most frequent co-authors are Douglas Louis Noordsy, MD, Erick S. Allen, MD and George J. Cuchural, MD.

CMS Open Payments shows 640 general payments to Dr. Hurlbut from 67 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $1,864.

Dmand AI lists 1 award for Dr. Hurlbut, most recently CMS Stage 1 EHR in 2013.

Dr. Hurlbut graduated from UTMB Health in 1990. Dr. Hurlbut is a member of AAN.

Dr. Hurlbut is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.